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A B S T R A C T The receptor alterations involved in catecholamine-induced desensitization of adenylate cyclase in human neutrophils have been investigated as has the ability of hydrocortisone to modify such alterations. Incubation of human neutrophils with isoproterenol for 3 h in vitro resulted in an 86% reduction in the ability of isoproterenol to stimulate cyclic AMP accumulation in the cells. Two types of receptor alterations were documented. There was a 40% reduction in the number of beta adrenergic receptors (42 vs. 25 fmol/mg protein, P < 0.005) present after desensitization as assessed by [3H] dihydroalprenolol ( [3H]DHA) binding. In addition the receptors appeared to be relatively uncoupled from adenylate cyclase. This uncoupling was assessed by examining the ability of the agonist isoproterenol to stabilize a high-affinity form of the receptor, detected by computer modelling of competition curves for [3H]DHA binding. Desensitized receptors were characterized by rightward-shifted agonist competition curves. When hydrocortisone was added to the desensitizing incubations (combined treatment) there was a statistically significant attenuation in the desensitization process as assessed by the ability of isoproterenol to increase cyclic AMP levels in the cells. Although combined treatment did not prevent the decline in receptor number, it did attenuate the uncoupling of the receptors. Combined treatment resulted in competition curves intermediate between the control and the rightward-shifted desensitization curves. Prednisolone was similar to hydrocortisone in attenuating isoproterenol-induced uncoupling. Thus, steroids appeared to attenuate INTRODUCTION Beta adrenergic receptors undergo regulation in a variety of situations (1) . Catecholamine exposure from endogenous or exogenous sources may lead to diminished physiologic responsiveness to subsequent catecholamine challenge in lung (2) and other tissues. Steroid hormones appear to increase beta adrenergic responsiveness as evidenced by enhanced inotropic responses in heart muscle (3), enhanced vascular response (4, 5) , and enhanced hepatic glucose production (6) upon catecholamine stimulation. Dog lungs undergo desensitization of the bronchodilatory response to isoproterenol upon prolonged isoproterenol exposure. Methylprednisolone administration restores isoproterenol responsiveness in the dog lung (7) . The relationship between these opposing regulatory influences is of interest, since both catecholamines and steroid hormones are secreted in acute and chronic states of stress. Further, both catecholamines and steroid hormones may be simultaneously administered in the management of critical illness.
(N), and the catalytic moiety of adenylate cyclase (C) (8) . Curve modelling methods applied to competition binding data have demonstrated that a high-affinity complex is formed between the agonist and the beta adrenergic receptor (9, 10) . Studies in frog erythrocyte membranes have demonstrated that the high-affinity complex appears to be composed of the hormone (H), receptor (R), and N-site as a high-affinity ternary complex, HRN (11, 12) . This N-site normally assists in the "coupling" of receptor occupation to enzyme activation through the action of guanine nucleotides. Guanine nucleotides such as guanosine triphosphate act through the N-site once the HRN complex is formed to convert the high-affinity state of the receptor into a low-affinity state, resulting in release of bound hormone and activation of the catalytic moiety of adenylate cyclase. Thus, the formation of the high-affinity state and the subsequent actions of the N-site are essential to normal beta adrenergic receptor function (8) .
The overall process of isoproterenol-induced desensitization (diminished receptor action) may be composed of both down-regulation (diminished receptor amount) and uncoupling. (14) .
Binding studies. The methods for preparing and assaying neutrophil membranes for beta adrenergic receptors were previously described (14) . Tritiated Cyclic AMP. Neutrophils incubated as described above were collected and resuspended in a buffer consisting of 75 mM Tris, 5 mM MgCl2, 1 mM EGTA, and 0.5 mM isobutylmethylxanthine at pH 7.65. The ability of these cells to accumulate cAMP was assessed by incubation for 2 min at 370C in the presence or absence of 10-4 M (-)-isoproterenol.
The radioimmunoassay for cAMP was performed with cAMP kits obtained from New England Nuclear, Boston, MA.
RESULTS
Beta adrenergic receptor desensitization. Neutrophils exposed to isoproterenol for 3 h underwent desensitization of catecholamine-stimulated adenylate cyclase. The ability of neutrophils preexposed to isoproterenol to accumulate cAMP in response to subsequent catecholamine stimulation was reduced by 86% (Fig. 1) . This desensitization was associated with a 40% reduction in receptor density (down-regulation, Table  I state of beta adrenergic receptors was examined. Beta adrenergic receptors obtained from cells incubated under control conditions demonstrated complex, shallow isoproterenol competition curves very similar to our prior experience (13) (Fig. 2) . The binding parameters derived from the computer modelling are contained in Table II isoproterenol competition curves for receptors derived from neutrophils simultaneously exposed to isoproterenol and hydrocortisone. As seen in Fig. 2 , the composite agonist competition curve is shallow and complex, and lies between the control and isoproterenol treatment curves. The resultant EC50 for the isoproterenol plus hydrocortisone treatment curve is intermediate between the EC50 values for the control and the isoproterenol treatment curves (Table II) . Two states of the beta adrenergic receptor were also observed after combined treatment, with dissociation constants, KH and KL, as noted in Table III . The presence of hydrocortisone markedly attenuated the isoproterenol-induced change in KL such that a statistically significant difference from the control KL was no longer found. As a result, the KL/KH for the isoproterenol plus hydrocortisone treatment curve is intermediate between the control and the isoproterenol treatment values. Thus, isoproterenol-induced desensitization reduces the stability of the agonist-induced high-affinity state formation, while the presence of hydrocortisone attenuates this reduction. The ability of hydrocortisone to stabilize high-affinity state formation is further indicated by the observation that pretreatment of cells with hydrocortisone alone impedes the ability of the guanine nucleotide 5'-guanylyl imidodiphosphate [GPP(NH)P] to shift the competition curve to the right, resulting in a competition curve whose EC50 is threefold lower than that for control curves performed in the presence of GPP(NH)P.
If the alterations induced by hydrocortisone were typical of steroid-mediated mechanisms, one would expect several characteristics. First, one would not expect to see a hydrocortisone effect with brief incubations. Second, steroid congeners might induce similar alterations. We examined these two characteristics in a second series of desensitization experiments. In this series of experiments the competition curve derived from the isoproterenol treatment group was shifted to the right with an EC50 of 2,100±230 nM (nine experiments), similar to the value of 2,600 nM in Table II . In these experiments two site fits to the competition curves from the desensitized cells could not be obtained, presumably due to the marked uncoupling. When hydrocortisone (2.7 ,uM final concentration) was added for the last 15 min of the 3-h isoproterenol treatment the resultant competition curve was very similar to the isoproterenol treatment curve. The ECso for the 15-min treatment was indistinguishable from the isoproterenol treatment value (five experiments). Thus, no effect of hydrocortisone was observed with brief incubations.
Prednisolone was chosen as a hydrocortisone congener to determine whether other steroids induced similar effects. Prednisolone was examined in a manner parallel to hydrocortisone. The two concentrations chosen were designed to correspond to 2 and 1.2 gM hydrocortisone, both well within physiologically achievable levels. After exposure of neutrophils to 20 Mug/dl prednisolone sodium succinate (equivalent to 2 MuM hydrocortisone) + isoproterenol, competition curves were more shallow and shifted to the left compared to isoproterenol treatment curves (EC50 930±100 nM vs. 2,100±230 nM, P < 0.001), as seen after hydrocortisone exposure. The value of KL/KH for this prednisolone + isoproterenol curve was 80±4.6 (n = 5), and was distinct from the isoproterenol treatment value in Table II (P < 0.001). However, addition of prednisolone at a lower concentration, 12 This uncoupling is highly analogous to that demonstrated for the homologous desensitization of frog erythrocyte beta adrenergic receptors (8, 9, 11) .
In humans, diminished antagonist binding to beta adrenergic receptors has been demonstrated after in vitro (13) or in vivo (15) (16) (17) (18) (19) (20) exposure to catecholamines. Diminished cAMP accumulation or adenylate cyclase activity has also been observed in human leukocytes exposed for prolonged periods to catecholamines (21) (22) (23) (24) (25) (26) (27) (28) (29) . However, these prior studies with human leukocytes have not investigated the status of uncoupling of the beta adrenergic receptors as assessed by detailed competition curves. Thus, the present studies are the first to indicate that the desensitized human leukocyte beta adrenergic receptor is uncoupled as a result of diminished high-affinity state formation by agonists.
This study indicates that catecholamine exposure results in at least two alterations of the beta adrenergic receptor in human neutrophils: down-regulation (reduction in receptor density) and uncoupling (reduction in high-affinity state formation). Under the conditions tested, hydrocortisone appears to diminish the desensitization primarily by attenuating the uncoupling process without affecting down-regulation. This attenuation appears to be associated with a stabilizing effect on high-affinity state formation. Harden et al. (30) have demonstrated that there may be different time courses for the processes of down-regulation and receptor uncoupling due to catecholamine exposure. Thus, the beta adrenergic receptor may undergo uncoupling before measureable down-regulation. Since down-regulation and uncoupling have separate time courses and different responses to hydrocortisone, they may be distinct yet related processes. Further examination of the molecular events underlying these processes will better determine how they might be related. Separate control of these regulatory processes could allow overall beta adrenergic responsiveness to be very finely tuned according to physiologic need.
The observed steroid-induced attenuation of catecholamine-induced desensitization agrees well with other data regarding the relationship of steroid hormones to catecholamine action. Steroid hormones increase beta adrenergic receptor density in human (14, 31, 32) and animal (33, 34) tissues. Further, steroid hormones enhance adenylate cyclase action (assessed either by enzyme activity or cAMP accumulation) (14, 28, (35) (36) (37) . Finally, hydrocortisone induces a tightened coupling of receptor and enzyme in neutrophils exposed in vitro (13) . Thus, steroids exert a positive effect, in general, upon the beta adrenergic receptoradenylate cyclase system in either the presence or absence of desensitizing influences. The best physiologic correlate of our in vitro observations is tachyphylaxis (desensitization) to isoproterenol action in bronchi. Repeated exposure to isoproterenol results in progressively less bronchodilation in response to subsequent isoproterenol administration. Hydrocortisone administration has been shown to return desensitized human bronchial tissue to a normal degree of relaxation (38) . A similar effect of methylprednisolone exists in dogs (7) . Thus, our observations provide an insight into the physiologically observable attenuating effects of steroids upon catecholamine-induced desensitization.
Our present observations are consistent with our prior demonstration of tightened coupling when neutrophils are exposed to steroid alone (13) . Whether the observed alterations in coupling in the combined treatment group represent a direct steroid effect upon desensitization alone, or a combination of steroid-induced supersensitization and catecholamine-induced desensitization is not known at this time. The biochemical basis for the effects of steroids on the agonistinduced uncoupling of receptors remains to be determined.
